Background 27
Introduction 52
Staphylococcus aureus is responsible for a wide spectrum of diseases ranging from superficial skin 53 infections to life-threatening bacteraemia, endocarditis and toxic shock syndrome (1). Whilst β-lactam 54 antibiotics are first choice therapeutics for S. aureus infections, the prevalence of skin and soft tissue 55 infections (SSTIs) caused by methicillin-resistant S. aureus (MRSA) strains has necessitated the use of 56 second line therapeutics including co-trimoxazole (SXT), which is comprised of trimethoprim (TMP) 57 and sulfamethoxazole (SMX) (2). However, SXT therapy is ineffective against deep-seated infections 58 and long-term use often leads to the emergence of resistance. 59 SXT has been proposed to cause DNA damage by limiting the production of thymine, 60 leading to stalled replication forks (3, 4) . Whilst the bacterium attempts to repair this damage by 61 inducing the mutagenic SOS response, it is not clear whether this contributes to staphylococcal survival 62 during antibiotic exposure. This is important because a greater understanding of the mechanisms by 63 which S. aureus survives SXT exposure may identify targets for new therapeutics that enhance 64 treatment efficacy. Therefore, the aims of this work were to identify the mechanisms by which SXT 65 damages S. aureus DNA, the repair systems that this pathogen uses to withstand this damage and the 66 consequences of repair for the emergence of resistance. 67 68
Materials and Methods

69
Bacterial strains and culture conditions 70
The bacterial strains used in this study are listed in Table 1 . S. aureus was cultured in Tryptic Soy Broth 71 (TSB) or Mueller Hinton Broth (MHB) supplemented with calcium (25 mg L -1 ) and magnesium (12.5 mg 72 L -1 ), to stationary phase (18 h) at 37 °C, with shaking (180 RPM). Media were supplemented with 73 antibiotics as required. 74
Mutants lacking functional rexB were complemented using pitet (5) containing the wild-type 75 rexBA operon. Primers (Table 2) were used to amplify the rexBA operon from USA300 JE2 genomic 76 4 DNA. The PCR product and pitet vector were digested and ligated using T4 ligase and transformed into 77
CaCl2-competent E. coli DH5α cells. Plasmid DNA was passaged through E. coli DC10B before 78 electroporation into S. aureus rexB mutants. Empty vector that did not contain the rexBA operon was 79 used as a control. 80 81
Minimum Inhibitory Concentration (MIC) Assay 82
The MIC was determined using the broth microdilution protocol described previously (6). The 83 concentration of SXT was calculated based on the concentration of TMP. MICs were determined by 84 incubation in air or in anaerobic jars containing Anaerogen gas packs at 37 °C for 18 h. 85
86
SXT killing kinetics 87
Washed stationary-phase S. aureus cells were inoculated into fresh MHB or TSB (3 ml) to a density of 88 2 x 10 8 CFU ml -1 containing 4 μg ml -1 SXT and incubated at 37°C with shaking (180 RPM). Bacterial 89 survival was determined over time by quantification of colony-forming units using the Miles and Misra 90 method (7). Percentage survival was calculated by comparing CFU counts at specific time points with 91 the starting inoculum. Similar studies were performed anaerobically in pre-reduced broth in bijoux 92 tubes, supplemented with 4 μg ml -1 SXT, and incubated statically at 37 °C with the vessel caps loosened 93 in an anaerobic jar containing an Anaerogen gas pack. 94 95
Disc-diffusion Assay 96
Stationary phase S. aureus cultures were adjusted to an OD600 of 0.063 (0.5 McFarland) in TSB and used 97 to inoculate TSA plates using a cotton swab. Antibiotic discs containing 2.5 μg of either SXT or TMP 98 (Oxoid) were placed onto the inoculated agar and incubated at 37 °C under aerobic or anaerobic 99 conditions for 17 h. The zone of inhibition was measured as the total diameter of the cleared bacterial 100 lawn, minus the diameter of the antibiotic disc. 101 102 5
Mutation rate analyses 103
Mutation rates were determined as described previously (8, 9) . Briefly, thirty parallel cultures of S. 104 aureus adjusted to ~5 x 10 5 CFU ml -1 for each condition or strain were inoculated into TSB with or 105 without 0.05 μg ml -1 or 0.1 μg ml -1 SXT and incubated at 37 °C, with shaking, for 24 h. After incubation, 106 10 cultures were selected at random, and total CFU counts determined. Subsequently, 100 μl of each 107 of the 30 cultures were spread on TSA plates containing rifampicin (100 μg ml -1 ) before incubation at 108 37 °C for 24 h. The number of rifampicin-resistant colonies on each plate were counted, and the 109 mutation rate with 95% confidence intervals calculated using the maximum-likelihood setting of the 110 FALCOR mutation rate calculator (8). 111 112
recA-reporter assay 113
Induction of the SOS response in S. aureus was determined using strains containing a recA-gfp reporter 114 construct. This was constructed by transforming S. aureus with pCN34 containing gfp under the control 115 of the recA promoter. Primers (Table 2) were used to amplify the recA promoter region (3) from JE2 116 wild-type genomic DNA, and the gfp gene from the pCL55 P3 GFP plasmid (10). These products were 117 combined by overlapping extension PCR, digested and ligated into phosphatase-treated and digested 118 pCN34. Empty vector without the recA-gfp construct served as a control. Vectors were constructed in 119 E. coli DC10B and transformed directly with into S. aureus WT JE2 or rexB::Tn mutant. 120 Stationary phase cultures of recA-gfp reporter strains washed twice and resuspended in TSB 121 supplemented with kanamycin (90 μg ml -1 ) to maintain the plasmid. Cultures at ~3.33 x 10 8 CFU ml -1 122 were exposed to a range of SXT concentrations (0.01 μg ml -1 to 8 μg ml -1 ) in black-walled microtiter 123 plates with shaking at 37 °C for 17 h in a TECAN Infinite® 200 PRO microplate reader, where OD600 and 124 GFP relative fluorescent units (RFU) (Excitation: 475 nm; Emission: 525 nm) was measured every 1000 125 seconds. Measurements were blanked against uninoculated wells and GFP fluorescence normalised to 126 OD600 readings to determine recA expression levels. 127 128 6
Endogenous Reactive oxygen species (ROS) production 129
Production of ROS was detected using the cell permanent 2',7'-dichlorodihydrofluorescein diacetate 130 dye (H2DCFDA), which is converted to fluorescent DCF by oxidative cleavage of acetate groups (11). A 131 96 well microtitre plate assay was prepared in a similar format to the recA-gfp reporter assay, with the 132 addition of 25 μM H2DCFDA and various concentrations of SXT. Bacterial strains were washed and 133 inoculated to ~3.33 x 10 8 CFU ml -1 . Plates were incubated with shaking at 37 °C as described previously, 134 and OD600 and RFU (Excitation: 495 nm; Emission: 525nm) was measured every 1000 s. OD600 values 135 were blanked against uninoculated wells and RFU values blanked to untreated wells. Fluorescence 136 values were normalised to OD600 readings to determine production of ROS relative to cell number. 137
138
Statistical Analysis 139
Means or medians were calculated from at least three biologically independent replicates and 140 analysed by Student's t test (two tailed, unpaired, assuming equal variances), One-way ANOVA or Two-141 way ANOVA corrected for multiple comparison using GraphPad Prism (V7.0) as described in the figure 142 legends. 143
144
Results
145
Inactivation of rexB sensitises S. aureus to SXT 146
To investigate the role of bacterial DNA repair in the susceptibility of S. aureus to SXT, a panel of S. 147 aureus transposon mutants previously used to study mutagenic DNA repair during exposure to H2O2 148 (rexA, rexB, recF, umuC and dinB) (9), were subjected to MIC and disc diffusion susceptibility assays. 149
Strains from two distinct genetic backgrounds were used: SH1000, a methicillin-sensitive S. aureus 150 (MSSA) strain, and JE2, a community-associated methicillin-resistant S. aureus (CA-MRSA) strain of the 151 USA300 lineage, responsible for severe skin infections that are often treated with SXT (12, 13). 152
The MIC values for both wild-type (WT) strains indicated susceptibility to SXT and TMP (< 2 µg 153 ml -1 ), but resistance to SMX (>512 µg ml -1 ) (14) ( Fig. 1A ). Disruption of rexB in both JE2 and SH1000 154 7 strains lowered the MIC of SXT and TMP by 2-4-fold and 16-fold for SMX, whilst complementation of 155 the rexB mutant either fully or partially restored WT levels of susceptibility (Fig. 1A) . The JE2 recF 156 mutant was also more susceptible than the WT to all three antibiotics, however, dinB or umuC mutants 157 only resulted in a slightly increased susceptibility to SXT. 158 Consistent with the MIC data, disc diffusion assays showed that inactivation of rexB 159 significantly increased the susceptibility of S. aureus to SXT and TMP, relative to the WT (Fig. 1B,C) . 160
Complementation of the rexB mutant (prexBA) reduced susceptibility close to WT levels, confirming 161 that changes in susceptibility were attributed to the function of RexAB complex ( Fig. 1B,C) . By contrast, 162 inactivation of dinB or umuC did not significantly increase zone sizes for either antibiotic (Fig. 1B,C) . 163
However, the recF-deficient mutant showed an increase in susceptibility to TMP in the JE2 strain ( Fig.  164 1C), indicating that both rexB and recF contribute to the repair of DNA damage caused by TMP. 165
Next, we investigated the role of DNA repair in the survival of S. aureus exposed to SXT at the 166 clinical breakpoint concentration (4 μg ml -1 ) (14). There was a ~20-fold reduction in survival over 24 h 167 for the WT, umuC or dinB mutants in the JE2 background ( Fig. 1D ), indicative of relatively high tolerance 168
to SXT. By contrast, survival of the recF mutant was reduced by >20-fold, whilst the rexB mutant 169 showed >5000-fold reduction in CFU counts relative to the WT after 24 h. Complementation of the 170 rexB mutant increased survival 10-fold relative to a plasmid only control ( Fig. 1E ). Studies with SH1000 171 confirmed a role for rexBA in modulating susceptibility of S. aureus to SXT, with a 12-fold greater loss 172 of CFU counts of the rexB mutant relative to WT ( Fig. 1F ), whilst complementation of the rexB mutant 173 restored survival levels close to those of the WT (Fig. 1F) which could provide an explanation for the DNA damage phenotype described above (Fig. 1) . 180 8 Experiments detailed thus far were performed in TSB, which contains a low concentration of thymidine 181 (0.25 µM, (15) ). To investigate the influence of exogenous thymidine on SXT activity, the growth of WT 182 and rexB mutants were determined in TSB supplemented with doubling dilutions of SXT and thymidine 183 via chequerboard assays ( Fig. 2A-D) . As expected, the presence of high concentrations of thymidine 184 enabled growth of WT strains of both JE2 and SH1000 at normally growth inhibitory concentrations of 185 SXT (15) ( Fig. 2A,C) . 186
The thymidine-dependent activity of SXT means that culture media compositions greatly affect 187 antibiotic susceptibility (15, 16) . For example, Mueller-Hinton Broth (MHB) contains >16-fold more 188 thymidine than TSB (15) . Consistent with the chequerboard data, the efficacy of SXT in MHB was 189 reduced relative to TSB, with detectable bacterial growth of both WT strains observed even at high 190 concentrations of SXT, likely attributable to the elevated thymidine concentration ( Fig. 2E,F) . 191
To explore the effect of exogenous thymidine on the bactericidal activity of SXT, killing assays 192 were undertaken in MHB. In contrast to TSB (Fig. 1D ) there was almost no killing of the S. aureus JE2 193 WT and dinB, umuC and recF mutants by SXT (4 μg ml -1 ) in MHB over 24 h (Fig. 2G ). However, despite 194 the presence of exogenous thymidine, survival of the rexB mutant was >2000-fold lower than that of 195 the WT, (Fig. 2G) , whilst complementation of the mutant (prexBA) significantly promoted survival 196 relative to a plasmid only control (Fig. 2H ). Similar results were seen for the SH1000 strain, with the 197 WT surviving, whilst viability of the rexB mutant was reduced >6000-fold relative to the inoculum (Fig.  198 2I), with complementation significantly promoting survival (> 10-fold) ( Fig. 2I) . 199
Combined, these data demonstrate that the RexAB DNA repair complex is required for the 200 survival of S. aureus exposed to SXT, even when thymidine is available, suggesting that thymidine 201 limitation is not the only mechanism by which this antibiotic damages bacterial DNA. To determine whether the production of reactive oxygen species (ROS) contributes to SXT activity 206 against S. aureus, the susceptibility of WT and DNA repair mutants to the antibiotic was determined 207 under both aerobic and anaerobic conditions in low-thymidine TSB. In the absence of oxygen, the MIC 208 of WT S. aureus was increased 4-fold for both strains (Fig. 3A) . By contrast, the SXT MIC of the JE2 rexB 209 mutant only doubled under anaerobic conditions, whilst the MIC of the SH1000 rexB mutant was 210 unaffected by the presence of oxygen (Fig. 3A) . However, zones of inhibition from SXT antibiotic discs 211 were significantly reduced in the absence of oxygen for all strains and mutants, implying reduced 212 susceptibility (Fig. 3B ). Despite the reduced antibiotic activity of SXT under anaerobic conditions, the 213 rexB mutants were still more susceptible than the corresponding WT, with >10 and 2.5-fold greater 214 zone sizes for JE2 and SH1000 strains respectively (Fig. 3B) . 215
Next, we assessed the contribution of ROS to the bactericidal activity of SXT. In contrast to 216 assays performed in air, the WT strains were able to grow slightly under these conditions, however, 217 SXT prevented growth of the rexB mutants >2-fold by 24 h post inoculation (Fig. 3C,D) . 218
Complementation of the rexB mutant restored the WT phenotype (Fig. 3C,D) . Therefore, SXT exposure 219 causes bacteriostasis in the rexBA mutant but not the WT under anaerobic conditions. 220
The reduced activity of SXT under anaerobic conditions suggested that ROS contribute to the 221 bactericidal activity of SXT. Therefore, H2DCFDA dye was added to growth inhibition assays (Fig. 3E,F ) 222 to quantify and study the kinetics of ROS production during incubation under aerobic conditions. SXT 223 induced a dose-dependent fluorescent peak 4 h post inoculation for both WT and rexB mutant strains 224 in the JE2 background (Fig. 3G,H) , indicative of the generation of ROS in response to the antibiotic. A 225 second peak in ROS production after 13 h is apparent at lower concentrations of SXT as cells reach 226 stationary phase, which is likely a result of the bacterial starvation response associated with increased 227 endogenous oxidative stress (17). 228
Combined, these data provide strong evidence that SXT induces ROS that contribute to the 229 growth inhibitory activity and are essential for the bactericidal activity of the drug. Furthermore, these 230 findings demonstrate that SXT triggers similar levels of oxidative stress in both WT and rexB mutant, 231 10 indicating that the increased susceptibility of the mutant to the antibiotic is due to an inability to repair 232 damage, rather than increased generation of ROS. 233 234
RexAB is required for SXT-triggered induction of the SOS response 235
Given the importance of RexAB for the repair of DNA damage caused by SXT, we wanted to determine 236 how it affected the induction of the mutagenic SOS response associated with spontaneous antibiotic 237 resistance emergence. 238
Using a range of concentrations of SXT that induced a dose-dependent inhibition of growth for 239 both the JE2 WT and rexB mutant ( Fig. 4A-D) , the induction of recA expression was determined using 240 a recA-gfp reporter construct ( Fig. 4E-H) . In low-thymidine TSB, SXT exposure resulted in a dose-241 dependent increase in GFP signal (Fig. 4E ) similar to that observed for ROS production (Fig. 3G ), which 242 peaked at ~4 h, and then subsided before a second peak as the bacteria entered stationary phase (17, 243 18). However, whilst SXT triggered ROS production in the rexB mutant (Fig. 3H) , the antibiotic did not 244 induce recA expression in this strain (Fig. 4F) , revealing that RexAB is required for activation of the SOS 245
response. 246
In contrast to experiments done in TSB, recA was only weakly expressed during exposure to SXT in 247 high-thymidine MHB (Fig. 4D) , which is in keeping with the reduced activity of the antibiotic in this 248 medium ( Fig. 2E,F) . Consistent with the data from studies in TSB, there was a lack of recA expression 249 in the JE2 rexB mutant in response to SXT in MHB (Fig. 4E) . 250 251
RexAB is required for SXT-induced mutagenic DNA repair 252
De-repression of the SOS regulon leads to expression of the error-prone translesion DNA polymerase 253
UmuC, which catalyses mutagenic DNA repair that contributes to the acquisition of antibiotic 254 resistance (9, 19) . 255
To assess whether SXT promoted SOS-dependent mutagenesis in S. aureus, JE2 WT and DNA-256 damage repair mutants were exposed to sub-inhibitory concentrations of SXT in low-thymidine TSB. 257
Since the rexB mutant was much more susceptible to SXT treatment than the WT, only a low 258 concentration of the antibiotic (0.05 µg ml -1 , 0.2 x MIC of the mutant) could be used in this analyses. 259 SXT treatment resulted in an increase in the mutation rate of WT S. aureus (Fig. 5A) . By contrast to the 260 WT, SXT exposure did not increase the mutation rate of the rexB mutant, consistent with the inability 261 of the antibiotic to trigger induction of the SOS response in this strain (Fig. 4B, 5A) . 262
To determine whether the SXT-mediated increase in the mutation rate was due to induction 263 of the SOS response, we exposed the WT and mutants lacking umuC or dinB (an error prone 264 polymerase that is not part of the SOS response in S. aureus (19)) to SXT at 0.2 x MIC of the mutants 265 (0.1 µg ml -1 ). Consistent with the recA reporter data, the higher concentration of SXT used in these 266 experiments promoted the mutation rate of the WT strain to a greater extent than the lower dose ( Fig.  267 4A, 5A,B). SXT caused a similar increase in the mutation rate of the dinB mutant but had no effect on 268 the mutation rate of the umuC mutant (Fig. 5B) . The discovery that S. aureus is more susceptible to SXT in thymidine-poor medium is in keeping 285 with previous reports, which suggest that thymidine depletion contributes to the lethality of SXT via 286 the collapse of replication forks during DNA synthesis, which lead to DNA DSBs (4, 15, 25). However, 287 there was still a very large reduction in CFU counts of the rexB mutant exposed to SXT in the presence 288 of thymidine, indicating that thymidine limitation is not the only element responsible for DNA damage 289 in S. aureus. 290
In agreement with several reports that bactericidal antibiotics, including TMP, exert part of 291 their antibacterial effect via the generation of ROS (24, 26), we determined that the bactericidal effect 292 of SXT against S. aureus is dependent upon the availability of oxygen. Indeed, our data indicate that 293 ROS-mediated DNA damage makes a greater contribution to the bactericidal activity of SXT than the 294 inhibition of DNA-synthesis caused by thymidine depletion in aerobic conditions. However, whilst ROS 295 clearly make an important contribution to the bactericidal activity of SXT, the increased susceptibility 296 of the rexB mutant to this antibiotic under anaerobic conditions confirms that DNA damage can occur 297 independently of ROS. This may explain why there are phenotypic differences in the effects of SXT 298 exposure and thymineless death observed in thyA mutants deprived of thymine (24). 299
One drawback of SXT is the frequent emergence of resistance during long-term therapy (27). 300
In keeping with the induction of the SOS response, exposure of S. aureus to sub-inhibitory 301 concentrations of SXT was found to increase the mutation rate via UmuC, a low-fidelity DNA 302 polymerase, previously shown to mediate mutagenic DNA repair of bacteria exposed to ciprofloxacin 303 or H2O2 (9). Similar to what has been reported for ciprofloxacin and H2O2, SXT-induced increases in the 304 mutation rate was dependent upon RexAB (9). 305
In summary, the identification of RexAB as central to both SXT susceptibility and SOS 306 induction suggests that this protein complex is a promising target for novel therapeutic approaches 307 13 that could improve the efficacy of SXT and reduce the emergence of resistance. Such an approach may 308 also increase the range of MRSA infections that could be treated with SXT. 
